Related Experiment Videos

Effects of GABAB receptor antagonists on two models of focal epileptogenesis

S Brailowsky1, T Montiel, S Meneses

  • 1Departamento de Neurociencias, Universidad Nacional Autónoma de México. sbrailow@ifcsun 1.ifisiol.unam.mx

Brain Research
|December 8, 1995
PubMed

Insights

This study investigated GABAB receptor antagonists in epilepsy models. Systemic CGP-35348 inhibited both baclofen-induced epileptic patterns, while local phaclofen only suppressed one, suggesting differential GABAB receptor roles in cortical epilepsy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • GABAB receptors play a crucial role in regulating neuronal excitability.
  • Understanding their involvement in different epileptic syndromes is essential for developing targeted therapies.
  • GABA withdrawal syndrome (GWS) is a model of cortical epilepsy.

Purpose of the Study:

  • To investigate the acute effects of GABAB receptor antagonists phaclofen and CGP-35348 on two distinct types of cortical epileptogenic activity.
  • To differentiate the roles of GABAB receptors in baclofen-induced seizures and GABA withdrawal syndrome (GWS).

Main Methods:

  • Studied acute effects of phaclofen and CGP-35348 on epileptogenic activity induced by intracortical baclofen.
  • Investigated antagonist effects on GABA withdrawal syndrome (GWS) following chronic intracerebral GABA infusion.
  • Administered antagonists via intracortical microinjection and systemic administration in rat models.

Main Results:

  • Intracortical baclofen induced two patterns of electrographic discharges: pattern I (single spike-and-wave) and pattern II (polyspike-and-wave).
  • Local phaclofen suppressed pattern II but not pattern I or GWS.
  • Systemic CGP-35348 inhibited both pattern I and pattern II, but not GWS.
  • Neither intracortical nor systemic administration of antagonists affected GWS.

Conclusions:

  • GABAB receptors exhibit differential involvement in distinct cortical epileptic syndromes.
  • Systemic GABAB receptor blockade is effective against certain seizure types, but not GABA withdrawal syndrome.
  • These findings highlight the complexity of GABAB receptor function in epilepsy and suggest specific therapeutic targets.

Related Concept Videos